Global Cellular Immunotherapy Market Trends, Strategies And Opportunities In The Cellular Immunotherapy Market 2021-2030

Cellular Immunotherapy Market Report 2021: COVID 19 Growth And Change To 2030

Cellular Immunotherapy Global Market Report 2021: COVID 19 Growth And Change To 2030

The Business Research Company’s Cellular Immunotherapy Global Market Report 2021: COVID 19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, September 9, 2021 / — According to the new market research report ‘Cellular Immunotherapy Global Market Report 2021: COVID-19 Growth And Change’ published by The Business Research Company, the cellular immunotherapy market is expected to grow from $2.74 billion in 2020 to $3.59 billion in 2021 at a compound annual growth rate (CAGR) of 31%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.73 billion in 2025 at a CAGR of 17%. Increasing research and successful clinical trials in cellular immunotherapy are expected to drive the growth of the cellular immunotherapy market over the forecast period.

Request For A Sample For The Global Cellular Immunotherapy Market Report:

The cellular immunotherapy market consists of revenues generated by the companies engaged in developing, manufacturing, and sales of cellular immunotherapy drugs. Cellular immunotherapy is also known as adoptive cell therapy, a form of treatment that utilizes the cells of the immune system to eliminate diseases including non-Hodgkin lymphoma, cancer, and acute lymphoblastic leukemia.

Trends In The Global Cellular Immunotherapy Market
Companies in the cellular immunotherapy market are focusing on developing off-the-shelf allogeneic therapies for new and improved cancer treatment. Off-the-shelf allogeneic therapies are produced from the cells of donors instead of the patient cells as in the case of autologous therapy. Their non-customized nature provides advantages such as cost-effectiveness, large scale, fast, and quality control production. For instance, in November 2019, Precision Biosciences, Inc., a biotechnology company, has created a new generation allogeneic CAR-T therapy and is conducting an ongoing trial of this therapy by creating its first off-the-shelf allogeneic CAR-T therapy candidate known as PBCAR0191. This is in collaboration with Servier, an international pharmaceutical company, and is mainly for the patients in need of advanced cancer treatment options.

Global Cellular Immunotherapy Market Segments:
The global cellular immunotherapy market is further segmented based on therapy, primary indication, application and geography.
By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy
By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin Lymphoma, Others
By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Others
By Geography: The global cellular immunotherapy market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Cellular Immunotherapy Market At:

Cellular Immunotherapy Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides cellular immunotherapy market overviews, analyzes and forecasts market size and growth for the global cellular immunotherapy market, cellular immunotherapy market share, cellular immunotherapy market players, cellular immunotherapy market segments and geographies, cellular immunotherapy market’s leading competitors’ revenues, profiles and market shares. The cellular immunotherapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Cellular Immunotherapy Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Cellular Immunotherapy Market Organizations Covered: Novartis AG, Gilead Sciences Inc. (Kite Pharma), Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp (GC Pharma), AstraZeneca, Bristol-Myers Squibb, Pfizer Inc., Roche, Adicet Bio, ResTORbio, Celyad.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Get a quick glimpse of our services here:

Here is a list of reports from The Business Research Company similar to the Cellular Immunotherapy Global Market Report 2021:

Drugs For Immunotherapy Global Market Report 2021 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases), By End User: Hospitals & Clinics, Ambulatory Surgical Centers), COVID-19 Growth And Change

Blood Cancer Drugs Global Market Report 2021 – By Blood Cancer Type (Leukemia, Lymphoma, Myeloma), By Drugs (Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin)), By Treatment Approaches (Key Findings, Chemotherapeutic, MAbs/Targeted Therapies, Immunotherapeutic), COVID-19 Impact And Recovery

Oncology Drugs Market – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Cancer, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer), By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores), By Route Of Administration (Oral, Parenteral), And By Region, Opportunities And Strategies – Global Forecast To 2030

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Follow us on LinkedIn:
Follow us on Twitter:
Check out our Blog:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Leave a Reply

Your email address will not be published.